nucleosid
analog
prepar
via
two
facil
synthet
rout
precursor
nucleosid
obtain
sequenc
deacetyl
nucleosid
select
tosyl
primari
oh
final
treatment
potassium
thioacet
desir
thiolpyridin
protect
analog
f
g
obtain
sequenc
deacetyl
follow
thiopyridinyl
andor
condens
correspond
heterocycl
base
newli
synthes
peracetyl
sugar
precursor
obtain
via
novel
synthet
rout
glycosyl
donor
none
compound
show
antivir
activ
deriv
particularli
uracil
deriv
endow
interest
select
cytostat
action
varieti
murin
human
tumor
cell
cultur
nucleosid
analog
markedli
contribut
chemotherapi
cancer
viral
diseas
howev
novel
applic
still
explor
new
nucleosid
structur
reach
clinic
effect
agent
treatment
aid
herp
viru
infect
viral
hepat
fluorinecontain
nucleosid
analog
attract
compound
drawn
special
attent
fluorin
incorpor
either
base
moieti
sugar
part
frequent
lead
drastic
chang
biolog
activ
stabil
bioavail
recent
data
reveal
new
class
uncommon
fluorin
pyranonucleosid
promis
potenti
combat
rotavir
infect
treatment
colon
cancer
effici
antitumor
growth
inhibitor
experiment
data
also
suggest
human
poli
specif
ribonucleas
among
molecular
target
compound
could
act
therapeut
lower
mrna
turnov
rate
field
nucleosid
sulfur
chemistri
appear
particularli
fruit
develop
therapeut
agent
consider
interest
drawn
synthesi
thionucleosid
analog
nucleosidyl
disulfid
attract
candid
use
antivir
antineoplast
agent
latter
assess
prodrug
abl
interfer
hiv
revers
transcript
particularli
nucleosid
primari
hydroxyl
group
replac
thiolor
alkylthiogroup
promis
antivir
agent
sinc
disrupt
essenti
viral
macromolecular
methyl
process
view
data
recent
find
biolog
modifi
nucleosid
templat
antivir
anticanc
activ
turn
attent
possibl
improv
biolog
properti
molecul
thu
synthesis
seri
glucopyranosyl
nucleosid
analog
combin
pharmacolog
compat
fluorin
sulfurthiopyridin
moieti
sugar
part
paper
report
two
effici
method
prepar
suppli
data
biolog
activ
melt
point
record
meltemp
apparatu
uncorrect
thin
layer
chromatographi
tlc
perform
merck
precoat
plate
reaction
monitor
tlc
silica
gel
detect
uv
light
nm
char
sulfur
acid
flash
column
chromatographi
perform
use
silica
gel
mesh
merck
h
f
c
nmr
spectra
obtain
room
temperatur
brucker
see
front
matter
elsevi
inc
right
reserv
spectromet
mhz
respect
use
cdcl
methanold
cd
od
intern
tetramethylsilan
tm
h
c
intern
trifluorotoluen
tft
f
chemic
shift
express
part
per
million
follow
abbrevi
use
singlet
doublet
dd
doublet
doublet
dtr
doublet
triplet
multiplet
mass
spectra
obtain
micromass
platform
lc
esim
infrar
spectra
obtain
perkinelm
model
ftir
spectrophotomet
optic
rotat
measur
use
autopol
polarimet
reaction
carri
dri
solvent
acetonitril
distil
calcium
hydrid
store
molecular
siev
dimethylformamid
dmf
also
store
molecular
siev
pyridin
store
potassium
hydroxid
pellet
mixtur
methanol
ammonia
ml
n
benzoylcytosin
deriv
g
mmol
stir
h
room
temperatur
reaction
mixtur
concentr
crude
obtain
g
r
f
acoet
colorless
oil
product
use
without
purif
adenin
deriv
synthes
n
benzoyl
adenin
deriv
similar
procedur
describ
compound
obtain
g
r
f
acoet
colorless
oil
use
without
purif
solut
compound
g
mmol
ml
dri
pyridin
cool
ptoluenesulfonyl
chlorid
g
mmol
ml
dri
pyridin
ad
dropwis
stir
reaction
mixtur
store
room
temperatur
overnight
concentr
residu
gum
dissolv
pyridin
ml
acet
anhydrid
ad
ml
result
mixtur
stir
h
room
temperatur
meoh
ml
ad
quench
reaction
mixtur
concentr
high
vacuum
remov
solvent
mixtur
extract
two
ml
portion
ethyl
acet
neutral
aqueou
nahco
organ
layer
wash
nahso
ml
dri
anhydr
sodium
sulfat
evapor
dryness
purif
flash
chromatographi
hexaneacoet
gave
g
r
f
benzoyl
cytosin
n
benzoyl
cytosin
deriv
synthes
similar
procedur
describ
purifi
flash
chromatographi
hexaneacoet
deriv
obtain
g
r
f
hexaneacoet
white
foam
benzoyl
adenin
n
benzoyl
adenin
deriv
synthes
similar
procedur
describ
purifi
flash
chromatographi
hexaneacoet
compound
obtain
g
r
f
hexaneacoet
white
foam
tosyl
g
mmol
heat
potassium
thioacet
g
mmol
dmf
ml
h
reaction
mixtur
neutral
aqueou
nahco
mixtur
concentr
high
vacuum
pump
elimin
dmf
residu
partit
water
etoac
organ
extract
dri
anhydr
sodium
sulfat
filter
evapor
dryness
residu
purifi
flash
chromatographi
hexaneacoet
give
compound
g
r
f
hexaneacoet
white
solid
n
benzoyl
adenin
n
benzoyl
adenin
deriv
synthes
similar
procedur
describ
solut
thioacet
g
mmol
methanol
ammonia
ml
dtdp
g
mmol
dissolv
meohh
ml
ad
dropwis
mixtur
stir
room
temperatur
stir
h
reaction
mixtur
concentr
crude
final
purifi
flash
chromatographi
acoet
give
compound
g
r
f
acoet
white
foam
uracil
deriv
synthes
thioacet
similar
procedur
describ
purifi
flash
chromatographi
acoet
obtain
g
r
f
acoet
white
foam
uracil
deriv
synthes
thionucleosid
follow
similar
procedur
describ
disulfid
obtain
g
r
f
acoet
white
foam
uracil
deriv
synthes
similar
procedur
describ
purifi
flash
chromatographi
acoet
obtain
g
r
f
acoet
white
foam
solut
diol
g
mmol
dri
pyridin
ml
ad
ptoluenesulfonyl
chlorid
g
mmol
kept
h
room
temperatur
neutral
nahco
extract
ethyl
acet
ml
combin
extract
dri
anhydr
sodium
sulfat
evapor
dryness
purif
residu
flash
chromatographi
hexaneacoet
yield
titl
compound
g
r
f
hexaneacoet
colorless
oil
solut
g
mmol
dri
ptoluenesulfon
acid
g
mmol
anhydr
ch
cl
ml
ad
ml
mmol
kept
h
room
temperatur
reaction
mixtur
neutral
aqueou
nahco
extract
ch
cl
l
organ
layer
combin
dri
na
concentr
vacuo
residu
chromatograph
column
silica
gel
hexaneacoet
fraction
contain
product
combin
concentr
afford
g
r
f
hexaneacoet
offwhit
oil
tosyl
g
mmol
heat
potassium
thioacet
g
mmol
dmf
ml
h
reaction
mixtur
neutral
aqueou
nahco
mixtur
concentr
high
vacuum
pump
elimin
dmf
residu
partit
water
etoac
organ
extract
dri
anhydr
sodium
sulfat
filter
evapor
dryness
residu
purifi
flash
chromatographi
hexaneacoet
give
compound
g
r
f
hexaneacoet
yellow
syrup
mixtur
thymin
g
mmol
hmd
ml
mmol
saccharin
g
mmol
anhydr
ch
cn
ml
reflux
min
triacetyl
thiopyridyl
sugar
g
mmol
tin
chlorid
ml
mmol
ad
reaction
mixtur
reflux
h
cool
neutral
aqueou
sodium
bicarbon
extract
ch
cl
ml
organ
layer
wash
water
ml
dri
anhydr
sodium
sulfat
evapor
dryness
crude
underw
deacetyl
methanol
ammonia
ml
within
h
concentr
final
purifi
flash
chromatographi
acoet
give
compound
g
r
f
acoet
white
foam
mixtur
uracil
g
mmol
hmd
ml
mmol
saccharin
g
mmol
anhydr
ch
cn
ml
reflux
min
triacetyl
thiopyridyl
sugar
g
mmol
trimethylsilyl
trifluoromethanesulfon
ml
mmol
ad
reaction
mixtur
reflux
h
cool
neutral
aqueou
sodium
bicarbon
extract
ch
cl
ml
organ
layer
wash
water
ml
dri
anhydr
sodium
sulfat
evapor
dryness
crude
underw
deacetyl
methanol
ammonia
ml
within
h
concentr
final
purifi
flash
chromatographi
acoet
give
compound
g
r
f
acoet
white
foam
mixtur
g
mmol
hmd
ml
mmol
saccharin
g
mmol
anhydr
ch
cn
ml
reflux
min
triacetyl
thiopyridyl
sugar
g
mmol
trimethylsilyl
trifluoromethanesulfon
ml
mmol
ad
reaction
mixtur
reflux
h
cool
neutral
aqueou
sodium
bicarbon
extract
ch
cl
ml
organ
layer
wash
water
ml
dri
anhydr
sodium
sulfat
evapor
dryness
crude
underw
deacetyl
methanol
ammonia
ml
within
h
concentr
final
purifi
flash
chromatographi
acoet
give
compound
g
r
f
acoet
white
foam
mixtur
n
benzoyl
cytosin
g
mmol
hmd
ml
mmol
saccharin
g
mmol
anhydr
ch
cn
ml
reflux
min
triacetyl
thiopyridyl
sugar
g
mmol
trimethylsilyl
trifluoromethanesulfon
ml
mmol
ad
reaction
mixtur
reflux
h
cool
neutral
aqueou
sodium
bicarbon
extract
ch
cl
ml
organ
layer
wash
water
ml
dri
anhydr
sodium
sulfat
evapor
dryness
crude
underw
deacetyl
methanol
ammonia
ml
within
h
concentr
final
purifi
flash
chromatographi
acoet
give
compound
g
r
f
acoet
white
foam
mixtur
n
benzoyl
adenin
g
mmol
hmd
ml
mmol
saccharin
g
mmol
anhydr
ch
cn
ml
reflux
min
triacetyl
thiopyridyl
sugar
g
mmol
tin
chlorid
ml
mmol
ad
reaction
mixtur
reflux
h
cool
neutral
aqueou
sodium
bicarbon
extract
ch
cl
ml
organ
layer
wash
water
ml
dri
anhydr
sodium
sulfat
evapor
dryness
crude
underw
deacetyl
methanol
ammonia
ml
within
h
concentr
final
purifi
flash
chromatographi
acoet
give
compound
g
r
f
acoet
white
foam
antivir
assay
base
inhibit
virusinduc
cytopath
confluent
cell
cultur
cytostat
assay
inhibit
tumor
cell
prolifer
exponenti
grow
tumor
cell
cultur
accord
previous
describ
methodolog
antivir
assay
antihiv
assay
base
inhibit
virusinduc
cytopath
hel
herp
simplex
viru
type
murin
leukemia
murin
mammari
carcinoma
human
lymphocyt
cem
human
cervix
carcinoma
hela
cell
seed
microtit
plate
cem
hela
cell
per
llwell
presenc
differ
concentr
test
compound
cem
hela
day
viabl
cell
number
count
use
coulter
counter
apparatu
cytostat
concentr
cc
defin
compound
concentr
requir
inhibit
tumor
cell
prolifer
convers
dthd
thymin
urd
uracil
compound
free
base
human
recombin
thymidin
phosphorylas
uridin
phosphorylas
type
kindli
provid
dr
tp
roosild
la
vega
nevada
usa
measur
highpressur
liquid
chromatographi
hplc
analysi
determin
convers
activ
high
amount
recombin
enzym
incub
lm
dthd
tpbuffer
mm
trishcl
ph
mm
edta
mm
kh
po
k
hpo
mm
nacl
upbuff
tpbuffer
mm
nacl
instead
mm
min
aliquot
reaction
mixtur
withdrawn
heat
min
inactiv
enzym
dthd
urd
separ
thymin
uracil
separ
uracil
reversephas
column
merck
darmstadt
germani
quantifi
highpressur
liquid
chromatographi
hplc
analysi
allianc
water
milford
separ
perform
linear
gradient
buffer
b
mm
nah
po
mm
heptan
sulfon
acid
ph
buffer
b
acetonitril
min
buffer
b
acetonitril
min
linear
gradient
buffer
b
acetonitril
buffer
b
acetonitril
min
buffer
b
acetonitril
follow
equilibr
buffer
b
acetonitril
retent
time
thymin
dthd
respect
min
uracil
urd
respect
min
respect
min
uvbas
detect
perform
nm
two
main
strategi
use
synthesi
nucleosid
f
g
first
approach
scheme
focus
prepar
nucleosid
thymin
uracil
n
benzoyl
cytosin
n
benzoyl
adenin
use
precursor
toward
synthesi
spyridin
disulfid
readili
transform
correspond
upon
condens
purin
pyrimidin
base
afford
nucleosid
deprotect
nucleosid
methanol
ammonia
gave
fulli
unprotect
deriv
f
g
base
protect
benzoyl
deriv
e
obtain
e
treat
naohethanolpyridin
treatment
ptoluenesulphonyl
chlorid
dri
pyridin
direct
acetyl
free
hydroxyl
acet
anhydridepyridin
afford
desir
acetyl
deriv
good
yield
subsequ
tosyl
deriv
treatment
potassium
thioacet
hot
n
ndimethylformamid
dmf
convert
correspond
thioacet
thymin
uracil
n
benzoyl
cytosin
n
benzoyl
adenin
respect
deprotect
bprotect
thionucleosid
methanol
ammonia
situ
thiopyridinyl
h
meoh
disulfid
dtdp
room
temperatur
led
desir
deriv
reaction
complet
within
h
isol
yield
spyridin
disulfid
gener
higher
attempt
fulli
unprotect
thionucleosid
result
format
correspond
symmetr
disulfid
thiopyridinyl
also
led
desir
sdipyridin
disulfid
noteworthi
decomposit
product
obtain
deprotectionthiopyridinyl
n
benzoyl
cytosin
n
adenin
deriv
respect
order
circumv
difficulti
chose
investig
rout
thionucleosid
could
gener
suitabl
thiopyridin
sugar
precursor
altern
synthet
pathway
compound
envis
appropri
glycosyl
donour
prepar
suitabl
sugar
describ
scheme
initi
select
remov
group
start
materi
led
format
diol
select
sulfonyl
ptoluenesulphonyl
chlorid
pyridin
led
compound
treat
dihydropyran
dhp
ptoluenesulphon
acid
monohydr
dri
ch
cl
order
give
compound
satisfactori
overal
yield
displac
tosyl
group
thioacetyl
moieti
proceed
without
difficulti
afford
compound
precursor
readili
avail
glucofuranos
hydrolysi
aqueou
trifluoroacet
acid
room
temperatur
direct
acetyl
deprotect
glycosyl
donor
use
methanol
ammonia
direct
thiopyridinyl
mol
excess
dtdpmeohh
follow
acetyl
led
desir
thiopyridin
sugar
order
prepar
target
sdipyridin
disulfid
g
previous
synthes
nucleosid
well
glycosyl
reaction
correspond
purin
pyrimidin
base
sugar
follow
direct
deacetyl
employ
new
compound
wellcharacter
nmr
uv
spectroscopi
mass
spectrometri
element
analysi
h
nmr
data
obtain
newli
synthes
reveal
compound
b
configur
j
yz
must
also
mention
desir
compound
show
strong
infrar
absorpt
cm
oac
cm
sac
h
nmr
spectra
promin
methyl
signal
appear
ascrib
acetylthio
moieti
methyl
peak
correspond
acetoxyl
group
moreov
data
h
nmr
spectra
obtain
newli
synthes
nucleosid
f
g
reveal
absenc
methyl
peak
correspond
acetoxyl
group
presenc
moieti
whose
proton
peak
appear
ppm
stabil
target
compound
assign
month
storag
either
organ
solut
solid
phase
perform
nmr
spectroscopi
comparison
primarili
nmr
spectra
target
molecul
storabl
compound
could
clearli
reveal
ident
proton
nmr
spectra
compound
c
f
g
evalu
antivir
activ
wide
varieti
dna
rna
virus
includ
herp
simplex
viru
type
also
examin
cytostat
activ
murin
leukemia
murin
mammari
carcinoma
human
lymphocyt
cem
human
cervix
carcinoma
hela
cell
compound
tabl
acetylsubstitut
analog
data
shown
show
appreci
antiprolif
activ
likewis
glucopyranosyl
pyrimidin
dinucleosid
deriv
show
appreci
cytostat
action
evalu
tumor
cell
line
ic
lm
tabl
howev
correspond
mononucleosid
endow
pronounc
cytostat
activ
cell
cultur
particular
especi
uracil
deriv
show
consider
cytostat
potenc
murin
human
cem
hela
cell
also
cytostat
prolifer
human
embryon
lung
hel
fibroblast
ic
lm
lm
respect
crandel
felin
kidney
cell
crfk
ic
lm
canin
madindarbi
kidney
cell
mdck
ic
lm
lm
respect
convers
adenin
cytosin
deriv
show
poor
cytostat
activ
lm
tabl
somewhat
intrigu
among
mononucleotid
deriv
contain
base
markedli
cytostat
bear
thymin
cytosin
adenin
base
fluorouracil
deriv
prove
equal
cytostat
murin
human
cell
well
leukemia
mammari
carcinoma
cervix
carcinoma
lymphoma
tumor
cell
molecular
basi
antiprolif
activ
fluorouracil
deriv
current
unknown
compound
expos
purifi
recombin
thymidin
phosphorylas
tpase
uridin
phosphorylas
type
upas
hydrolyz
free
pyrimidin
base
condit
thymidin
expos
tpase
uridin
expos
upas
readili
convert
thymin
uracil
respect
data
shown
find
indic
molecul
exert
potenc
via
intact
nucleosid
moieti
anabolit
deriv
thereof
rather
catabol
metabolit
ie
free
also
clear
inact
seri
compound
group
play
import
role
concert
uracil
base
express
pronounc
cytostat
activ
fact
decout
recent
report
dideoxyribonucleosid
disulfid
found
deriv
contain
rather
bulki
moieti
disulfid
part
molecul
ie
nitrophenyl
butyl
hexyl
actyl
also
cytostat
other
agreement
presenc
rather
bulki
entiti
disulfid
compound
well
exact
molecular
mechan
cytostat
activ
current
subject
studi
mutati
mutandi
compound
could
view
potenti
lead
compound
modif
order
redesign
synthes
potent
cytostat
agent
prepar
seri
bear
natur
modifi
purin
pyrimidin
develop
highli
effici
synthet
rout
none
new
compound
show
antivir
potenc
subtox
concentr
compound
particular
endow
signific
cytostat
potenc
view
novel
lead
compound
modif
would
therefor
interest
explor
structureact
relationship
modifi
base
part
well
sugar
portion
incorpor
differ
chemic
entiti
